Prevalence of Metabolic Syndrome in Patients with Psoriasis

Table 3

The associations of MS with patient characteristics in psoriasis patients.

		MS
Psoriasis group		(+)	(−)	P
		M±SD (Median)	M±SD (Median)
^+Duration of disease		12.29±9.65	10.42±8.55	0.277
^+Age of onset		39.73±17.03	28.03±15.56	0.001**
		𝑛 (%)	𝑛 (%)	^++P
Gender	Male	21 (41.2%)	24 (58.8%)	0.023*
	Female	40 (62.5%)	30 (37.5%)
	No	28 (54.9%)	23 (45.1%)
	Ex-smoker	12 (66.7%)	6 (33.3%)	0.166
Smoking	Active smoker	17 (41.4%)	24 (58.6%)
	Passive smoker	4 (80.0%)	1 (20.0%)
PASI	Mild-moderate	39 (51.3%)	37 (48.7%)	0.604
	Severe	22 (56.4%)	17 (43.6%)

⁺Student’s t-test, ⁺⁺Chi-square test, * 𝑃<0.05, ** 𝑃<0.01.